Jun 23, 2021 / 04:00PM GMT
Steve Seedhouse - Raymond James Financial, Inc. - Analyst
Okay. Well, good afternoon, everyone, and welcome to the next session of the second day of Raymond James Human Health Innovation Conference. Really, really pleased to welcome VBI Vaccines for a fireside chat. During this session, I'm joined by Jeff Baxter and David Anderson from the Company. This is a company, obviously, we've covered and recommended for some time. And a lot of interesting programs in the vaccine space, both therapeutic and prophylactic, that are underway. And we're going to touch on most of those in our conversation.
So just at the outset, I wanted to start with COVID, Jeff and David, because, obviously, we're in the midst and emerging from the global pandemic. And you, amongst others, have been working on a COVID vaccine. And you're in Phase 1, studying and anticipating data, I believe, in the second quarter. So wanted to just ask you for an update on that expectation and how that study has been going.
Jeff Baxter - VBI Vaccines Inc. - President & CEO
Well, firstly, good
VBI Vaccines Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Mar 05, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers